Blue Bird Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Blue Bird Tbk trades at Rp1,575 (market cap 3.89T, 574.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Blue Bird Tbk is far larger — about 23.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Blue Bird Tbk is more actively traded (574.8K versus 214.9K). Which is the better fit depends on your goals.
| BIRD | OBAT | |
|---|---|---|
Market Cap | 3.89T | 164.65B |
Volume | 574.8K | 214.9K |
Lot | 5.75K | 2.15K |
Turnover | 903.2M | 51.97M |
Average Price | 1,571.32 | 241.85 |
Value | 903.2M | 51.97M |
Indicative Equilibrium Price | 1,575 | 240 |
Indicative Equilibrium Volume | 16 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Blue Bird Tbk (the Company) was established on March 29, 2001 based on Notarial Deed No. 11 of Dian Pertiwi, S.H.
Read more on BIRD →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →